FTXH vs. LGHT ETF Comparison
Comparison of First Trust Nasdaq Pharmaceuticals ETF (FTXH) to Langar Global HealthTech ETF (LGHT)
FTXH
First Trust Nasdaq Pharmaceuticals ETF
FTXH Description
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Grade (RS Rating)
Last Trade
$28.09
Average Daily Volume
3,198
50
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.Grade (RS Rating)
Last Trade
$10.42
Average Daily Volume
913
31
Performance
Period | FTXH | LGHT |
---|---|---|
30 Days | -0.59% | -0.59% |
60 Days | -3.12% | -1.40% |
90 Days | -3.96% | -1.14% |
12 Months | 16.01% |
1 Overlapping Holdings
Symbol | Grade | Weight in FTXH | Weight in LGHT | Overlap | |
---|---|---|---|---|---|
ALKS | B | 1.06% | 0.66% | 0.66% |
FTXH Overweight 49 Positions Relative to LGHT
Symbol | Grade | Weight | |
---|---|---|---|
BMY | B | 8.89% | |
JNJ | D | 6.95% | |
PFE | D | 6.81% | |
ABBV | D | 6.56% | |
MRK | F | 6.31% | |
GILD | C | 4.43% | |
CAH | B | 4.09% | |
VTRS | A | 3.97% | |
UTHR | C | 3.9% | |
ZTS | D | 3.61% | |
JAZZ | B | 3.45% | |
AMGN | D | 3.37% | |
LLY | F | 3.11% | |
BIIB | F | 3.06% | |
REGN | F | 2.51% | |
CRL | C | 2.47% | |
OGN | D | 2.43% | |
ELAN | D | 1.83% | |
MEDP | D | 1.79% | |
NBIX | C | 1.39% | |
HALO | F | 1.19% | |
EXEL | B | 1.12% | |
PBH | A | 0.98% | |
PRGO | B | 0.97% | |
CORT | B | 0.82% | |
ACLX | C | 0.73% | |
PTGX | C | 0.71% | |
TGTX | B | 0.69% | |
ALNY | D | 0.65% | |
ITCI | C | 0.63% | |
ADMA | B | 0.62% | |
INCY | C | 0.62% | |
RNA | D | 0.6% | |
AMRX | C | 0.55% | |
VCEL | B | 0.54% | |
ACAD | D | 0.54% | |
BPMC | C | 0.53% | |
VRTX | F | 0.51% | |
KYMR | D | 0.5% | |
ROIV | C | 0.5% | |
INSM | C | 0.49% | |
TWST | D | 0.48% | |
KRYS | B | 0.48% | |
EXAS | D | 0.44% | |
VKTX | F | 0.44% | |
BMRN | D | 0.43% | |
SRPT | D | 0.42% | |
IONS | F | 0.41% | |
MYGN | F | 0.29% |
FTXH Underweight 30 Positions Relative to LGHT
Symbol | Grade | Weight | |
---|---|---|---|
ISRG | A | -15.39% | |
GEHC | F | -8.56% | |
RMD | C | -6.71% | |
IQV | D | -6.34% | |
DXCM | D | -5.51% | |
PODD | C | -5.26% | |
VEEV | C | -5.15% | |
PHG | D | -4.87% | |
ZBH | C | -3.57% | |
BNTX | D | -3.53% | |
ALGN | D | -2.85% | |
MASI | A | -2.46% | |
DOCS | C | -2.06% | |
MRNA | F | -1.72% | |
PRCT | B | -1.27% | |
TNDM | F | -0.54% | |
IRTC | D | -0.44% | |
PRVA | B | -0.44% | |
OMCL | C | -0.42% | |
LFST | C | -0.31% | |
TDOC | C | -0.28% | |
PGNY | F | -0.25% | |
EVH | F | -0.22% | |
SDGR | C | -0.21% | |
GDRX | F | -0.2% | |
ALHC | C | -0.2% | |
PHR | F | -0.17% | |
ACCD | D | -0.07% | |
MODV | C | -0.03% | |
TBRG | B | -0.03% |
FTXH: Top Represented Industries & Keywords
LGHT: Top Represented Industries & Keywords